{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:34:53Z","timestamp":1772728493494,"version":"3.50.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019211","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2630604","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:20:18Z","timestamp":1771831218000},"page":"563-573","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Real-world treatment switching and healthcare costs of onabotulinumtoxinA and calcitonin gene-related peptide monoclonal antibodies in Medicare patients with chronic migraine: a retrospective claims analysis"],"prefix":"10.1080","volume":"29","author":[{"given":"Yanan","family":"Dong","sequence":"first","affiliation":[{"name":"AbbVie Inc","place":["North Chicago, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziling","family":"Mao","sequence":"additional","affiliation":[{"name":"AbbVie Inc","place":["North Chicago, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaliza","family":"Dominguez","sequence":"additional","affiliation":[{"name":"AbbVie Inc","place":["North Chicago, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Jin","family":"Park","sequence":"additional","affiliation":[{"name":"AbbVie Inc","place":["North Chicago, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"e_1_3_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14709"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01941.x"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02223.x"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02046.x"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12878"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-013-0385-0"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14247"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2349791"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12055"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102416678382"},{"key":"e_1_3_9_15_1","unstructured":"BOTOX [onabotulinumtoxinA]. Package Insert. AbbVie Inc.; 2023 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/103000Orig1s5325Correctedlbl.pdf"},{"key":"e_1_3_9_16_1","unstructured":"AIMOVIG [erenumab-aooe]. Package Insert. Amgen Inc.; 2025 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761077s026lbl.pdf"},{"key":"e_1_3_9_17_1","unstructured":"AJOVY [fremanezumab-vfrm]. Package Insert. Teva Pharmaceutical USA Inc.; 2025 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761089s031lbl.pdf"},{"key":"e_1_3_9_18_1","unstructured":"EMGALITY [galcanezumab-glnm]. Package Insert. Eli Lilly and Company; 2025 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761063s010lbl.pdf"},{"key":"e_1_3_9_19_1","unstructured":"QULIPTA [atogepant]. Package Insert. AbbVie Inc.; 2025 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215206Orig1s000lbl.pdf"},{"key":"e_1_3_9_20_1","unstructured":"VYEPTI [eptinezumab-jjmr]. Package Insert. Lundbeck Seattle BioPharmaceuticals Inc.; 2025 [cited 2025 Aug 4]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761119s009s012lbl.pdf"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1040-x"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.18058"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000205185"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.10.1119"},{"key":"e_1_3_9_25_1","unstructured":"Optum Clinformatics Data Mart Database (2007\u20132025)."},{"key":"e_1_3_9_26_1","unstructured":"U.S. Bureau of Labor Statistics Consumer Price Index. [cited 2025 Aug 4]. Available from: https:\/\/www.bls.gov\/cpi\/"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00404.x"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2630604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:31:42Z","timestamp":1772724702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2630604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2630604"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2630604","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}